Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Collins

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|May 21, 2020
Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP)Abigail Pepin, Nima Aghdam, Sarthak Shah, et al.
Frontiers in Oncology|May 21, 2016
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University ExperienceCatherine Mercado, Marie-Adele Kress, Robyn A Cyr, et al.
Radiation Oncology (London, England)|December 16, 2014
Proctitis following stereotactic body radiation therapy for prostate cancerDaniel Y Joh, Leonard N Chen, Gerald Porter, et al.
The Prostate|May 22, 2014
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsiesLeonard N Chen, Rachel S Rubin, Eugide Othepa, et al.
Frontiers in Oncology|February 4, 2021
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation TherapyMichael Carrasquilla, Michael L Creswell, Abigail N Pepin, et al.
Frontiers in Oncology|December 19, 2018
A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation TherapyMichael Sosin, Surupa Sen Gupta, Jessica S Wang, et al.
Radiation Oncology (London, England)|November 5, 2013
Potency preservation following stereotactic body radiation therapy for prostate cancerOlusola Obayomi-Davies, Leonard N Chen, Aditi Bhagat, et al.
Archives of Pathology & Laboratory Medicine|December 31, 2015
Respiratory Cytology--Current Trends Including Endobronchial Ultrasound-Guided Biopsy and Electromagnetic Navigational Bronchoscopy: Analysis of Data From a 2013 Supplemental Survey of Participants in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic CytologyCharles D Sturgis, Carrie B Marshall, Guliz A Barkan, et al.
Radiation Oncology (London, England)|March 19, 2013
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experienceLeonard N Chen, Simeng Suy, Sunghae Uhm, et al.
Journal of Hematology & Oncology|March 29, 2011
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancerEric K Oermann, Simeng Suy, Heather N Hanscom, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|May 21, 2020
Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP)Abigail Pepin, Nima Aghdam, Sarthak Shah, et al.
Frontiers in Oncology|May 21, 2016
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University ExperienceCatherine Mercado, Marie-Adele Kress, Robyn A Cyr, et al.
Radiation Oncology (London, England)|December 16, 2014
Proctitis following stereotactic body radiation therapy for prostate cancerDaniel Y Joh, Leonard N Chen, Gerald Porter, et al.
The Prostate|May 22, 2014
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsiesLeonard N Chen, Rachel S Rubin, Eugide Othepa, et al.
Frontiers in Oncology|February 4, 2021
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation TherapyMichael Carrasquilla, Michael L Creswell, Abigail N Pepin, et al.
Frontiers in Oncology|December 19, 2018
A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation TherapyMichael Sosin, Surupa Sen Gupta, Jessica S Wang, et al.
Radiation Oncology (London, England)|November 5, 2013
Potency preservation following stereotactic body radiation therapy for prostate cancerOlusola Obayomi-Davies, Leonard N Chen, Aditi Bhagat, et al.
Archives of Pathology & Laboratory Medicine|December 31, 2015
Respiratory Cytology--Current Trends Including Endobronchial Ultrasound-Guided Biopsy and Electromagnetic Navigational Bronchoscopy: Analysis of Data From a 2013 Supplemental Survey of Participants in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic CytologyCharles D Sturgis, Carrie B Marshall, Guliz A Barkan, et al.
Radiation Oncology (London, England)|March 19, 2013
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experienceLeonard N Chen, Simeng Suy, Sunghae Uhm, et al.
Journal of Hematology & Oncology|March 29, 2011
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancerEric K Oermann, Simeng Suy, Heather N Hanscom, et al.
Pageof 13